Combined Molecular and Clinical Model Predicts Chemotherapy Response in Breast Cancer
A study evaluating 44 patients with HR+/HER2− breast cancer found that combining clinical features with gene expression profiles predicted neoadjuvant ...
Tag: HR+/HER2- breast cancer
Overweight Breast Cancer Study Links NOTCH2 Mutations to Endocrine Therapy Resistance
An integrative multi-omics study of Chinese female breast cancer patients reveals distinct genomic alterations in overweight individuals and identifies NOTCH2 ...
Gene Panel Predicts Response to Crucial Breast Cancer Therapy
Researchers unveil a groundbreaking immune-based genomic signature that promises to revolutionize treatment strategies for hormone receptor-positive, HER2-negative breast cancer by ...
CDK4/6 Inhibitors Boost First-Line Breast Cancer Therapy
In an ambitious stride toward optimizing treatment for hormone receptor-positive (HR+)/HER2-negative advanced breast cancer, a recent comprehensive network meta-analysis has ...
POPULAR NEWS
-
Look-Ahead Genomic Mating Optimizes Simulated Aquaculture Breeding Across Varying Horizons
-
Renewable Nanomedicines Require Rigorous Performance Metrics Beyond Natural Origin Alone
-
Multiparametric MRI Tracks Rapid Early Adaptation in Remaining Donor Kidneys
-
Controlled Dehydration-Rehydration Selectively Enriches Ginsenoside F2 in Hydroponic Ginseng Sprouts